Question 1

What is the catalog number for Betaxolol Impurity 17?

Accepted Answer

The catalog number for Betaxolol Impurity 17 is RM-B050117.

Question 2

What sizes are available for Betaxolol Impurity 17?

Accepted Answer

Betaxolol Impurity 17 is available in the following size(s): 10 mg, 100 mg, 25 mg, 50 mg.

Question 3

How many pack sizes does Betaxolol Impurity 17 come in?

Accepted Answer

Betaxolol Impurity 17 is available in 4 different pack sizes.

Question 4

Is Betaxolol Impurity 17 in stock?

Accepted Answer

Betaxolol Impurity 17 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 7

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Betaxolol Impurity 17

Product Specifications

CAS Number

Synonyms

Molecular Formula

Molecular Weight

Target Alternative Name

Available Sizes

Frequently Asked Questions

Explore Other Products

Alpha-1-Antitrypsin (SERPINA1) (Hepatocellular & Histiocytic Marker) (AAT/3167R), CF740 conjugate, 0.1mg/mL

KCTD9 (NM_017634) Human Over-expression Lysate

FAM3C (NM_001040020) Human Over-expression Lysate

CD45RA (158-4D3), CF488A conjugate, 0.1mg/mL

Amberlite® IR120 (H+)

EGFR (C-term) (incl. pos. control) Mouse Monoclonal Antibody [Clone ID: 13G8]